Impact of gadolinium-based contrast agent in the assessment of Crohn's disease activity: Is contrast agent injection necessary?
نویسندگان
چکیده
منابع مشابه
Gadolinium-DTPA: A New Contrast Agent
Gadolinium (Gd)-DTPA-dimeglumine (tradename: Magnevist?) is the first commercially available contrast agent for magnetic resonance tomography (MRT). As a result of the very favourable results from preclinical and clinical investigations Magnevist? was granted a product license for cranial and spinal MRT in the Federal Republic of Germany in early February this year. Magnevist? is a paramagnetic...
متن کاملGadolinium as a contrast agent for NMR.
Gadolinium chloride (GdCl3) was studied as a contrast agent for nuclear magnetic resonance. This rare-earth element dramatically alters proton resonance (paramagnetic moment = 10.8 Bohr magnetons). Acute toxicity was determined by intravenous injections in mice; mean lethal dose was 100-200 mg of GdCl3 . 6 H2O/kg. Changes in T1 of plasma, kidney, liver, and brain of mice and rats were measured ...
متن کاملLocalized Aortic Root Dissection Secondary to Contrast Agent Injection: Feasibility of Conservative Follow-up With Echocardiography
Introduction: Iatrogenic aortocoronary dissection (ACD) is a nightmare in interventional cardiology. Although ACD is rarely reported, the real-world prevalence is suspected of being higher due to unreported cases. The right coronary artery (RCA) ostium is involved in the majority of cases, and dissections are usually limited to the aortic sinus in half of the clinical presentat...
متن کاملSynthesized Gd2O3 nanoparticles as contrast agent
Introduction: Gd (III) ion has been known to be the best metal ion in the periodic table that can be used as a T1 MRI contrast agent. Gadolinium have 7 unpaired electrons and these electrons can make magnetic area. No other metal ions possess unpaired electron more than this. CAs based on the element Gd are classified as “positive”, by opposition to “negative” CAs. Nowadays, G...
متن کاملGadolinium-Based Contrast Agent Accumulation and Toxicity: An Update.
In current practice, gadolinium-based contrast agents have been considered safe when used at clinically recommended doses in patients without severe renal insufficiency. The causal relationship between gadolinium-based contrast agents and nephrogenic systemic fibrosis in patients with renal insufficiency resulted in new policies regarding the administration of these agents. After an effective s...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Magnetic Resonance Imaging
سال: 2015
ISSN: 1053-1807
DOI: 10.1002/jmri.25024